In conclusion, our results demonstrate that IDH mutations and the accumulation of their oncometabolite 2HG profoundly alter glioblastoma cell behavior across multiple biological levels, including proliferation, cell cycle regulation, apoptosis, migration, and phenotypic plasticity. Here, IDH1 is linked to glioblastoma.